Guardant Health
GH
#1121
Rank
$21.01 B
Marketcap
$155.35
Share price
-2.17%
Change (1 day)
58.65%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2026 (TTM): -$0.46 Billion USD

According to Guardant Health 's latest financial reports the company's current earnings are $1.18 Billion USD. In 2025 the company made an earning of -$0.42 Billion USD, an increase over its 2024 earnings that were of -$0.44 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$0.46 Billion8.84%
2025 -$0.42 Billion-4.03%
2024 -$0.44 Billion-9.12%
2023 -$0.48 Billion-26.73%
2022 -$0.66 Billion69.96%
2021 -$0.39 Billion56.35%
2020 -$0.25 Billion252.69%
2019 -$69.73 Million-17.22%
2018 -$84.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Neogen
NEOG
-$67.67 Million-85.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-$0.26 Billion-44.40%๐Ÿ‡บ๐Ÿ‡ธ USA